Furthermore, some growth factors, such as VEGF, enhance the transendothelial migration process by promoting the adhesion of breast cancer cells to the endothelium and by disrupting VE-cadherin complexes that form tight junctions [60]. The gene discussed is CDH5; the disease is breast carcinoma.